세계의 카프노그래피 장비 시장 : 제품별, 기술별, 용도별, 최종 사용자별, 지역별 예측(-2030년)

The global capnography equipment market is projected to reach USD 0.67 billion by 2030 from USD 0.53 billion in 2025, at a CAGR of 4.6% during the forecast period.

The capnography equipment market is experiencing significant growth, driven by the increasing prevalence of respiratory conditions such as COPD, asthma, and sleep apnea, along with a rising number of surgeries that require continuous patient monitoring. There is heightened awareness of the importance of early detection of respiratory issues, advancements in sensor technology and portable monitoring devices, and a broader application of capnography in critical care and emergency settings, all of which are further boosting demand.

Additionally, the growing use of capnography for procedural sedation, the shift toward noninvasive monitoring methods, and government initiatives that support patient safety standards in hospitals and outpatient care centers are key factors contributing to market expansion.

"By product, the capnography accessories & disposables segment accounted for the largest market share in 2024."

Capnography accessories & disposables represent the largest segment of the capnography equipment market, primarily due to their crucial role in ensuring accurate and reliable CO2 monitoring in various clinical settings. This category includes nasal and oral CO2 cannulas, airway adapters, sampling lines, and filters, all of which are essential for both mainstream and sidestream capnography systems. The high consumption rate, the need for single-patient usage to prevent cross-contamination, and frequent replacement requirements significantly drive market demand. Moreover, the increasing number of surgical procedures, a growing emphasis on patient safety during anesthesia and sedation, and the widespread adoption of capnography in critical care and emergency departments further reinforce the dominance of accessories and disposables in the overall market.

"By application, the cardiac care segment accounted for the largest market share in 2024."

The cardiac care segment represents the largest share of the capnography equipment market by application. This is primarily due to the critical need for continuous monitoring of respiratory function in patients with cardiovascular conditions. Capnography is widely used during cardiac surgeries, in intensive care units, and for patients undergoing procedures that require anesthesia or sedation. It provides real-time insights into ventilation, perfusion, and overall patient stability. Several factors contribute to the strong demand for capnography in cardiac care settings. These include the increasing prevalence of cardiovascular diseases, the growing number of cardiac procedures, and a heightened focus on patient safety and the early detection of respiratory issues. As a result, cardiac care has become the leading application segment in the capnography market.

"The US is expected to grow at the highest CAGR during the forecast period."

The US is projected to experience the highest CAGR in the North American capnography equipment market due to several key factors. The country has a well-established healthcare infrastructure that supports the widespread adoption of advanced patient monitoring technologies in hospitals, ambulatory surgical centers, and critical care units. The increasing prevalence of respiratory and cardiovascular disorders, along with a rising number of surgical procedures requiring anesthesia and sedation, drives the demand for accurate and continuous monitoring of carbon dioxide (CO2) levels. Additionally, supportive government initiatives, stringent patient safety regulations, and significant investments in healthcare technology innovation are contributing to market growth. The presence of major capnography equipment manufacturers, complemented by robust distribution networks and ongoing product development, further establishes the US as the fastest-growing market in the region.

A summary of the key participants (supply side) in the capnography equipment market referenced in this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
• By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)

The prominent players in the capnography equipment market are Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Masimo (US), GE Healthcare (US), Becton, Dickinson and Company (US), Dragerwerk AG & Co. KGaA (Germany), Nihon Kohden Corporation (Japan), ICU Medical, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), ZOLL Medical Corporation (US), EDAN Instruments, Inc. (China), Hamilton Medical (Switzerland), Nonin (US), SCHILLER (Switzerland), and ResMed Inc. (US).

Research Coverage:

The report analyzes the capnography equipment market and estimates its size and future growth potential based on various segments such as product, application, end user, and region. It also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders and new entrants in this market with information on the closest approximations of the revenue numbers for the overall capnography equipment market. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing prevalence of respiratory diseases, clinical benefits of capnography over pulse oximetry, rising number of surgeries and target diseases requiring CO2 monitoring, and technological advancements), restraints (complex regulatory framework for approval of capnography equipment and high equipment and maintenance costs), opportunities (increased availability of clinical research evidence, growth opportunities for healthcare industry in emerging economies, and AI and data analytics integration), and challenges (lack of skilled technicians & specialized training to operate capnometers).
• Market Penetration: It provides detailed information about the products offered by the major players in the global capnography equipment market. The report is segmented by product, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global capnography equipment market.
• Market Development: Comprehensive understanding and analysis of profitable emerging markets by product, technology, application, end user, and region.
• Market Diversification: Detailed information on newly launched products, market expansion, current advancements, and investments in the global capnography equipment market.
• Competitive Assessment: Comprehensive assessment of market shares, growth strategies, product offerings, and capabilities of major competitors in the global capnography equipment market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 BASE NUMBER ESTIMATION
• 2.3 MARKET FORECAST APPROACH
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 ASSUMPTIONS
  • 2.5.1 MARKET SHARE ASSUMPTIONS
  • 2.5.2 RESEARCH ASSUMPTIONS
• 2.6 FACTOR ANALYSIS
• 2.7 RISK ASSESSMENT
• 2.8 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

• 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 3.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 3.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

4 PREMIUM INSIGHTS

• 4.1 CAPNOGRAPHY EQUIPMENT MARKET OVERVIEW
• 4.2 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
• 4.3 NORTH AMERICA: CAPNOGRAPHY EQUIPMENT MARKET, BY END USER AND COUNTRY, 2024 (USD MILLION)
• 4.4 GEOGRAPHIC SNAPSHOT OF CAPNOGRAPHY EQUIPMENT MARKET
• 4.5 CAPNOGRAPHY EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
  • 5.1.1 DRIVERS
    • 5.1.1.1 Increasing prevalence of respiratory diseases
    • 5.1.1.2 Clinical benefits of capnography over pulse oximetry
    • 5.1.1.3 Rising number of surgeries and target diseases requiring CO2 monitoring
    • 5.1.1.4 Technological advancements
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Complex regulatory framework for approval of capnography equipment
    • 5.1.2.2 High equipment and maintenance costs
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Increased availability of clinical research evidence
    • 5.1.3.2 Growth opportunities for healthcare industry in emerging economies
    • 5.1.3.3 AI and data analytics integration
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Lack of skilled technicians and need for specialized training for operating capnometers
• 5.2 UNMET NEEDS & WHITE SPACES
  • 5.2.1 UNMET NEEDS IN CAPNOGRAPHY EQUIPMENT MARKET
  • 5.2.2 WHITE SPACE OPPORTUNITIES
• 5.3 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 5.3.1 INTERCONNECTED MARKETS
  • 5.3.2 CROSS-SECTOR OPPORTUNITIES
• 5.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

6 INDUSTRY TRENDS

• 6.1 PORTER'S FIVE FORCES ANALYSIS
  • 6.1.1 THREAT OF NEW ENTRANTS
  • 6.1.2 BARGAINING POWER OF SUPPLIERS
  • 6.1.3 BARGAINING POWER OF BUYERS
  • 6.1.4 THREAT OF SUBSTITUTES
  • 6.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 6.2 MACROECONOMIC OUTLOOK
  • 6.2.1 INTRODUCTION
  • 6.2.2 GDP TRENDS AND FORECAST
  • 6.2.3 TRENDS IN GLOBAL RESPIRATORY CARE DEVICES INDUSTRY
  • 6.2.4 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY
• 6.3 SUPPLY CHAIN ANALYSIS
  • 6.3.1 PROMINENT COMPANIES
  • 6.3.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 6.3.3 END USERS
• 6.4 ECOSYSTEM ANALYSIS
• 6.5 PRICING ANALYSIS
  • 6.5.1 INDICATIVE SELLING PRICE OF TOP THREE APPLICATIONS, BY KEY PLAYER (2024)
  • 6.5.2 AVERAGE SELLING PRICE TREND OF CAPNOGRAPHY EQUIPMENT, BY TYPE (2022-2024)
  • 6.5.3 AVERAGE SELLING PRICE TREND OF CAPNOGRAPHY EQUIPMENT, BY REGION (2022-2024)
• 6.6 TRADE ANALYSIS
  • 6.6.1 IMPORT DATA FOR HS CODE 9018
  • 6.6.2 EXPORT DATA FOR HS CODE 9018
• 6.7 KEY CONFERENCES & EVENTS, 2025-2026
• 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 6.9 INVESTMENT & FUNDING SCENARIO
• 6.10 CASE STUDY ANALYSIS
  • 6.10.1 CASE STUDY 1: INCORPORATING CAPNOGRAPHY MONITORING IN PATIENT-CONTROLLED ANALGESIA (PCA) POST-OPERATIVE CARE
  • 6.10.2 CASE STUDY 2: AVAILABILITY AND USEFULNESS OF PORTABLE CAPNOMETERS IN CHILDREN WITH TRACHEOSTOMY
  • 6.10.3 CASE STUDY 3: RANDOMIZED CONTROLLED TRIAL OF CAPNOGRAPHY IN CORRECTION OF SIMULATED ET DISLODGEMENT
• 6.11 IMPACT OF 2025 US TARIFFS ON CAPNOGRAPHY EQUIPMENT MARKET
  • 6.11.1 INTRODUCTION
  • 6.11.2 KEY TARIFF RATES
  • 6.11.3 PRICE IMPACT ANALYSIS
  • 6.11.4 IMPACT ON COUNTRY/REGION
    • 6.11.4.1 US
    • 6.11.4.2 Europe
    • 6.11.4.3 Asia Pacific
  • 6.11.5 IMPACT ON END-USER INDUSTRIES

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 7.1 KEY EMERGING TECHNOLOGIES
  • 7.1.1 MAINSTREAM CAPNOGRAPHY
  • 7.1.2 SIDE-STREAM CAPNOGRAPHY
  • 7.1.3 WAVEFORM CAPNOGRAPHY
  • 7.1.4 COMPLEMENTARY TECHNOLOGIES
    • 7.1.4.1 Pulse oximetry
    • 7.1.4.2 Ventilators
• 7.2 TECHNOLOGY/PRODUCT ROADMAP
  • 7.2.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 7.2.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 7.2.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 7.3 PATENT ANALYSIS
• 7.4 FUTURE APPLICATIONS OF CAPNOGRAPHY EQUIPMENT
• 7.5 IMPACT OF AI/GEN AI ON CAPNOGRAPHY EQUIPMENT MARKET
  • 7.5.1 TOP USE CASES AND MARKET POTENTIAL
  • 7.5.2 BEST PRACTICES IN CAPNOGRAPHY EQUIPMENT PROCESSING
  • 7.5.3 CASE STUDIES OF AI IMPLEMENTATION IN CAPNOGRAPHY EQUIPMENT MARKET
  • 7.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 7.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN CAPNOGRAPHY EQUIPMENT MARKET

8 REGULATORY LANDSCAPE

• 8.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 8.1.2 REGULATORY FRAMEWORK
    • 8.1.2.1 North America
      • 8.1.2.1.1 US
    • 8.1.2.2 Europe
    • 8.1.2.3 Asia Pacific
      • 8.1.2.3.1 Japan
      • 8.1.2.3.2 India
      • 8.1.2.3.3 China
  • 8.1.3 INDUSTRY STANDARDS
• 8.2 CERTIFICATIONS, LABELING, ECO-STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 9.1 DECISION-MAKING PROCESS
• 9.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 9.2.2 KEY BUYING CRITERIA
• 9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 9.5 MARKET PROFITABILITY
  • 9.5.1 REVENUE POTENTIAL
  • 9.5.2 COST DYNAMICS
  • 9.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

10 CAPNOGRAPHY EQUIPMENT MARKET, BY PRODUCT

• 10.1 INTRODUCTION
• 10.2 EQUIPMENT
  • 10.2.1 MULTIPARAMETER CAPNOMETERS
    • 10.2.1.1 Handheld multiparameter capnometers
      • 10.2.1.1.1 Improved patient safety, portability, and inbuilt audible and visual alarms to aid adoption
    • 10.2.1.2 Conventional multiparameter capnometers
      • 10.2.1.2.1 Increasing number of complex surgeries involving anesthesia to support segmental growth
  • 10.2.2 STANDALONE CAPNOMETERS
    • 10.2.2.1 Handheld standalone capnometers
      • 10.2.2.1.1 Increasing number of emergency care visits and complex surgeries to propel market growth
    • 10.2.2.2 Conventional standalone capnometers
      • 10.2.2.2.1 Easy portability and use in critical care settings to boost segmental growth
• 10.3 SOFTWARE
  • 10.3.1 BETTER CLINICAL DECISION-MAKING AND PATIENT MANAGEMENT TO FUEL MARKET GROWTH
• 10.4 CAPNOGRAPHY ACCESSORIES & DISPOSABLES
  • 10.4.1 FAVORABLE REIMBURSEMENT SCENARIO TO SUPPORT MARKET GROWTH

11 CAPNOGRAPHY EQUIPMENT MARKET, BY TECHNOLOGY

• 11.1 INTRODUCTION
• 11.2 MAINSTREAM CAPNOGRAPHY
  • 11.2.1 HIGH ACCURACY, FAST RESPONSE TIME, AND IMPROVED SUITABILITY FOR NEONATES TO AID MARKET GROWTH
• 11.3 SIDESTREAM CAPNOGRAPHY
  • 11.3.1 RELIABLE MEASUREMENT OF END-TIDAL CO2 LEVELS TO PROPEL ADOPTION IN CLINICAL SETTINGS
• 11.4 MICROSTREAM CAPNOGRAPHY
  • 11.4.1 LIMITATIONS IN BLACK-BODY INFRARED TECHNOLOGY TO LIMIT USAGE IN OPERATING ROOMS

12 CAPNOGRAPHY EQUIPMENT MARKET, BY APPLICATION

• 12.1 INTRODUCTION
• 12.2 CARDIAC CARE
  • 12.2.1 INCREASING NUMBER OF CARDIOPULMONARY SURGERIES TO DRIVE MARKET GROWTH
• 12.3 TRAUMA & EMERGENCY CARE
  • 12.3.1 INCREASING NUMBER OF ROAD ACCIDENTS TO SPUR MARKET GROWTH
• 12.4 RESPIRATORY MONITORING
  • 12.4.1 RISING PREVALENCE OF TARGET RESPIRATORY CONDITIONS TO SUPPORT MARKET GROWTH
• 12.5 OTHER APPLICATIONS

13 CAPNOGRAPHY EQUIPMENT MARKET, BY END USER

• 13.1 INTRODUCTION
• 13.2 HOSPITALS
  • 13.2.1 FOCUS ON REDUCING AIRWAY-RELATED DEATHS IN ICU PATIENTS TO ACCELERATE MARKET GROWTH
• 13.3 AMBULATORY SURGERY CENTERS & HOME CARE SETTINGS
  • 13.3.1 INCREASING NUMBER OF REIMBURSEMENT-APPROVED MEDICAL PROCEDURES UNDER ASC PAYMENT SYSTEM TO DRIVE MARKET
• 13.4 OTHER END USERS

14 CAPNOGRAPHY EQUIPMENT MARKET, BY REGION

• 14.1 INTRODUCTION
• 14.2 NORTH AMERICA
  • 14.2.1 US
    • 14.2.1.1 US to dominate North American capnography equipment market during forecast period
  • 14.2.2 CANADA
    • 14.2.2.1 Rising prevalence of target respiratory diseases to support market growth
• 14.3 EUROPE
  • 14.3.1 GERMANY
    • 14.3.1.1 Developed healthcare infrastructure and high government investments to spur market growth
  • 14.3.2 UK
    • 14.3.2.1 Increasing target patient population and rising healthcare expenditure to propel market growth
  • 14.3.3 FRANCE
    • 14.3.3.1 Growing awareness of capnography monitoring procedures and increasing number of trauma cases to augment market growth
  • 14.3.4 ITALY
    • 14.3.4.1 Rise in diabetes cases and high geriatric population to boost market growth
  • 14.3.5 SPAIN
    • 14.3.5.1 Increasing prevalence of lifestyle diseases to drive demand for capnography equipment
  • 14.3.6 REST OF EUROPE
• 14.4 ASIA PACIFIC
  • 14.4.1 JAPAN
    • 14.4.1.1 Rising geriatric population and growing prevalence of obesity to augment market growth
  • 14.4.2 CHINA
    • 14.4.2.1 High target patient population and improved inpatient service availability to support market growth
  • 14.4.3 INDIA
    • 14.4.3.1 Favorable regulatory policies and high public healthcare expenditure to aid market growth
  • 14.4.4 AUSTRALIA
    • 14.4.4.1 Growing patient population and rising availability of grants to fuel market growth
  • 14.4.5 SOUTH KOREA
    • 14.4.5.1 Increased focus on R&D activities and high penetration of health insurance to propel market growth
  • 14.4.6 REST OF ASIA PACIFIC
• 14.5 LATIN AMERICA
  • 14.5.1 BRAZIL
    • 14.5.1.1 Improved healthcare sector and increased private-public investments to drive market
  • 14.5.2 MEXICO
    • 14.5.2.1 Favorable trade environment and easy entry of foreign players to fuel market growth
  • 14.5.3 REST OF LATIN AMERICA
• 14.6 MIDDLE EAST & AFRICA
  • 14.6.1 GCC COUNTRIES
    • 14.6.1.1 Healthcare infrastructural developments and increased focus on patient safety to drive market
  • 14.6.2 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

• 15.1 INTRODUCTION
• 15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CAPNOGRAPHY EQUIPMENT MARKET
• 15.3 REVENUE ANALYSIS, 2020-2024
• 15.4 MARKET SHARE ANALYSIS, 2024
  • 15.4.1 RANKING OF KEY MARKET PLAYERS
• 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 15.5.1 STARS
  • 15.5.2 EMERGING LEADERS
  • 15.5.3 PERVASIVE PLAYERS
  • 15.5.4 PARTICIPANTS
  • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 15.5.5.1 Company footprint
    • 15.5.5.2 Region footprint
    • 15.5.5.3 Product footprint
    • 15.5.5.4 Technology footprint
    • 15.5.5.5 Application footprint
    • 15.5.5.6 End-user footprint
• 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 15.6.1 PROGRESSIVE COMPANIES
  • 15.6.2 RESPONSIVE COMPANIES
  • 15.6.3 DYNAMIC COMPANIES
  • 15.6.4 STARTING BLOCKS
  • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 15.6.5.1 Detailed list of key startups/SMEs
    • 15.6.5.2 Competitive benchmarking of key startups/SMEs
• 15.7 COMPANY VALUATION & FINANCIAL METRICS
  • 15.7.1 FINANCIAL METRICS
  • 15.7.2 COMPANY VALUATION
• 15.8 BRAND/PRODUCT COMPARISON
• 15.9 COMPETITIVE SCENARIO
  • 15.9.1 PRODUCT APPROVALS
  • 15.9.2 DEALS

16 COMPANY PROFILES

• 16.1 KEY PLAYERS
  • 16.1.1 MEDTRONIC PLC
    • 16.1.1.1 Business overview
    • 16.1.1.2 Products offered
    • 16.1.1.3 Recent developments
      • 16.1.1.3.1 Product approvals
      • 16.1.1.3.2 Deals
    • 16.1.1.4 MnM view
      • 16.1.1.4.1 Right to win
      • 16.1.1.4.2 Strategic choices
      • 16.1.1.4.3 Weaknesses & competitive threats
  • 16.1.2 KONINKLIJKE PHILIPS N.V.
    • 16.1.2.1 Business overview
    • 16.1.2.2 Products offered
    • 16.1.2.3 Recent developments
      • 16.1.2.3.1 Product approvals
      • 16.1.2.3.2 Deals
    • 16.1.2.4 MnM view
      • 16.1.2.4.1 Right to win
      • 16.1.2.4.2 Strategic choices
      • 16.1.2.4.3 Weaknesses & competitive threats
  • 16.1.3 MASIMO CORPORATION
    • 16.1.3.1 Business overview
    • 16.1.3.2 Products offered
    • 16.1.3.3 Recent developments
      • 16.1.3.3.1 Product approvals
      • 16.1.3.3.2 Deals
    • 16.1.3.4 MnM view
      • 16.1.3.4.1 Right to win
      • 16.1.3.4.2 Strategic choices
      • 16.1.3.4.3 Weaknesses & competitive threats
  • 16.1.4 GE HEALTHCARE
    • 16.1.4.1 Business overview
    • 16.1.4.2 Products offered
    • 16.1.4.3 Recent developments
      • 16.1.4.3.1 Product approvals
      • 16.1.4.3.2 Deals
    • 16.1.4.4 MnM view
      • 16.1.4.4.1 Right to win
      • 16.1.4.4.2 Strategic choices
      • 16.1.4.4.3 Weaknesses & competitive threats
  • 16.1.5 BECTON, DICKINSON AND COMPANY
    • 16.1.5.1 Business overview
    • 16.1.5.2 Products offered
    • 16.1.5.3 MnM view
      • 16.1.5.3.1 Right to win
      • 16.1.5.3.2 Strategic choices
      • 16.1.5.3.3 Weaknesses & competitive threats
  • 16.1.6 DRAGERWERK AG & CO. KGAA
    • 16.1.6.1 Business overview
    • 16.1.6.2 Products offered
    • 16.1.6.3 Recent developments
      • 16.1.6.3.1 Product approvals
  • 16.1.7 NIHON KOHDEN CORPORATION
    • 16.1.7.1 Business overview
    • 16.1.7.2 Products offered
    • 16.1.7.3 Recent developments
      • 16.1.7.3.1 Deals
  • 16.1.8 ICU MEDICAL, INC.
    • 16.1.8.1 Business overview
    • 16.1.8.2 Products offered
    • 16.1.8.3 Recent developments
      • 16.1.8.3.1 Deals
  • 16.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 16.1.9.1 Business overview
    • 16.1.9.2 Products offered
    • 16.1.9.3 Recent developments
      • 16.1.9.3.1 Product launches
      • 16.1.9.3.2 Deals
  • 16.1.10 ZOLL MEDICAL CORPORATION
    • 16.1.10.1 Business overview
    • 16.1.10.2 Products offered
    • 16.1.10.3 Recent developments
      • 16.1.10.3.1 Deals
  • 16.1.11 EDAN INSTRUMENTS, INC.
    • 16.1.11.1 Business overview
    • 16.1.11.2 Products offered
  • 16.1.12 HAMILTON MEDICAL
    • 16.1.12.1 Business overview
    • 16.1.12.2 Products offered
    • 16.1.12.3 Recent developments
      • 16.1.12.3.1 Product launches
  • 16.1.13 NONIN
    • 16.1.13.1 Business overview
    • 16.1.13.2 Products offered
    • 16.1.13.3 Recent developments
      • 16.1.13.3.1 Product launches
      • 16.1.13.3.2 Deals
  • 16.1.14 SCHILLER
    • 16.1.14.1 Business overview
    • 16.1.14.2 Products offered
  • 16.1.15 RESMED INC.
    • 16.1.15.1 Business overview
    • 16.1.15.2 Products offered
• 16.2 OTHER PLAYERS
  • 16.2.1 BIONICS CO., LTD.
  • 16.2.2 BPL MEDICAL TECHNOLOGIES
  • 16.2.3 BURTONS MEDICAL EQUIPMENT, LTD.
  • 16.2.4 CRITICARE TECHNOLOGIES, INC.
  • 16.2.5 DIAMEDICA (UK) LIMITED
  • 16.2.6 INFINIUM MEDICAL
  • 16.2.7 SPACELABS HEALTHCARE
  • 16.2.8 NIDEK MEDICAL INDIA
  • 16.2.9 RECORDERS & MEDICARE SYSTEMS PVT. LTD.
  • 16.2.10 ZOE MEDICAL, INCORPORATED

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS